Matches in DBpedia 2014 for { <http://dbpedia.org/resource/David_R._Elmaleh> ?p ?o. }
Showing items 1 to 51 of
51
with 100 items per page.
- David_R._Elmaleh abstract "David R. Elmaleh is a scientist, inventor and entrepreneur. He is an inventor of three drugs that are in use in man or in late stage clinical trials including: the radiopharmaceutical preparation of (2FDG) which has been used in over a million PET imaging procedures, Beta-methyl modified fatty acid (BMIPP) a commercially successful cardiac SPECT agent, and Altropane which has completed Phase III clinical trials. He is a co-author on over 120 publications and an inventor on dozens of issued and pending patents in a range of disciplines, including molecular imaging and pharmaceuticals.".
- David_R._Elmaleh almaMater Hebrew_University_of_Jerusalem.
- David_R._Elmaleh occupation David_R._Elmaleh__1.
- David_R._Elmaleh wikiPageID "27646474".
- David_R._Elmaleh wikiPageRevisionID "591749848".
- David_R._Elmaleh almaMater Hebrew_University_of_Jerusalem.
- David_R._Elmaleh education "BSc, MS, and PhD".
- David_R._Elmaleh employer "Harvard Medical School and Pure Tech Ventures".
- David_R._Elmaleh hasPhotoCollection David_R._Elmaleh.
- David_R._Elmaleh knownFor "Work in Fluorine-18-FDG synthesis".
- David_R._Elmaleh name "David R. Elmaleh".
- David_R._Elmaleh name "Elmaleh, David".
- David_R._Elmaleh occupation "Professor and medical researcher".
- David_R._Elmaleh shortDescription "Pharmaceutical scientist".
- David_R._Elmaleh description "Pharmaceutical scientist".
- David_R._Elmaleh description "Pharmaceutical scientist".
- David_R._Elmaleh subject Category:Harvard_Medical_School_faculty.
- David_R._Elmaleh subject Category:Hebrew_University_of_Jerusalem_alumni.
- David_R._Elmaleh subject Category:Living_people.
- David_R._Elmaleh type CausalAgent100007347.
- David_R._Elmaleh type LivingPeople.
- David_R._Elmaleh type LivingThing100004258.
- David_R._Elmaleh type Object100002684.
- David_R._Elmaleh type Organism100004475.
- David_R._Elmaleh type Person100007846.
- David_R._Elmaleh type PhysicalEntity100001930.
- David_R._Elmaleh type Whole100003553.
- David_R._Elmaleh type YagoLegalActor.
- David_R._Elmaleh type YagoLegalActorGeo.
- David_R._Elmaleh type Agent.
- David_R._Elmaleh type Person.
- David_R._Elmaleh type Person.
- David_R._Elmaleh type Q215627.
- David_R._Elmaleh type Q5.
- David_R._Elmaleh type Agent.
- David_R._Elmaleh type NaturalPerson.
- David_R._Elmaleh type Thing.
- David_R._Elmaleh type Person.
- David_R._Elmaleh comment "David R. Elmaleh is a scientist, inventor and entrepreneur. He is an inventor of three drugs that are in use in man or in late stage clinical trials including: the radiopharmaceutical preparation of (2FDG) which has been used in over a million PET imaging procedures, Beta-methyl modified fatty acid (BMIPP) a commercially successful cardiac SPECT agent, and Altropane which has completed Phase III clinical trials.".
- David_R._Elmaleh label "David R. Elmaleh".
- David_R._Elmaleh sameAs m.0cc6w3c.
- David_R._Elmaleh sameAs Q5238809.
- David_R._Elmaleh sameAs Q5238809.
- David_R._Elmaleh sameAs David_R._Elmaleh.
- David_R._Elmaleh wasDerivedFrom David_R._Elmaleh?oldid=591749848.
- David_R._Elmaleh givenName "David".
- David_R._Elmaleh isPrimaryTopicOf David_R._Elmaleh.
- David_R._Elmaleh name "David Elmaleh".
- David_R._Elmaleh name "David R. Elmaleh".
- David_R._Elmaleh name "Elmaleh, David".
- David_R._Elmaleh surname "Elmaleh".